Illicit drug use and pulmonary arterial hypertension: Not so frequent

被引：0
作者：
Roche, Anne
Chaumais, Marie Camille
Perrin, Swanny
Jais, Xavier
Savale, Laurent
Camus, Philippe
Favrolt, Nicolas
Traclet, Julie
Cottin, Vincent
Sitbon, Olivier
Simmoneau, Gerald
Humbert, Marc
Bonniaud, Philippe
Montani, David
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Pulmonary hypertension; Epidemiology; Pharmacology;
D O I：
10.1183/13993003.congress-2016.OA259
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA259
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
    Mohammadi, Asma
    Matos, Wanessa F.
    Intriago, Cesar
    Thakkar, Keval
    Jahan, Nasrin
    Shah, Heeya
    Nishu, Rifath I.
    Marzban, Sima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [2] Drug-induced pulmonary arterial hypertension: a review
    Garg, Lohit
    Akbar, Ghulam
    Agrawal, Sahil
    Agarwal, Manyoo
    Khaddour, Leila
    Handa, Rishin
    Garg, Aakash
    Shah, Mahek
    Patel, Brijesh
    Dalal, Bhavinkumar D.
    HEART FAILURE REVIEWS, 2017, 22 (03) : 289 - 297
  • [3] Drug Interactions Associated With Therapies for Pulmonary Arterial Hypertension
    Narechania, Shraddha
    Malesker, Mark A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (06) : 349 - 359
  • [4] Drug-induced pulmonary arterial hypertension: a review
    Lohit Garg
    Ghulam Akbar
    Sahil Agrawal
    Manyoo Agarwal
    Leila Khaddour
    Rishin Handa
    Aakash Garg
    Mahek Shah
    Brijesh Patel
    Bhavinkumar D. Dalal
    Heart Failure Reviews, 2017, 22 : 289 - 297
  • [5] Management of Pulmonary Arterial Hypertension
    Jennalyn D. Mayeux
    Irene Z. Pan
    John Dechand
    Joshua A. Jacobs
    Tara L. Jones
    Stephen H. McKellar
    Emily Beck
    Nathan D. Hatton
    John J. Ryan
    Current Cardiovascular Risk Reports, 2021, 15
  • [6] Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
    Caldarone, Flora
    Gebhardt, Philippa
    Hoeper, Marius M.
    Olsson, Karen M.
    Fuge, Jan
    Park, Da-Hee
    Meltendorf, Tanja
    Kamp, Jan C.
    Stapel, Britta
    Richter, Manuel J.
    Gall, Henning
    Ghofrani, Hossein A.
    Kahl, Kai G.
    Heitland, Ivo
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [7] Management of Pulmonary Arterial Hypertension
    Mayeux, Jennalyn D.
    Pan, Irene Z.
    Dechand, John
    Jacobs, Joshua A.
    Jones, Tara L.
    McKellar, Stephen H.
    Beck, Emily
    Hatton, Nathan D.
    Ryan, John J.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2021, 15 (01)
  • [8] The Use of Antidepressants and the Risk of Idiopathic Pulmonary Arterial Hypertension
    Fox, Benjamin D.
    Azoulay, Laurent
    Dell'Aniello, Sophie
    Langleben, David
    Lapi, Francesco
    Benisty, Jacques
    Suissa, Samy
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (12) : 1633 - 1639
  • [9] Ambrisentan: a review of its use in pulmonary arterial hypertension
    Rivera-Lebron, Belinda N.
    Risbano, Michael G.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (06) : 233 - 244
  • [10] Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension
    Condon, David F.
    Agarwal, Stuti
    Chakraborty, Ananya
    Auer, Natasha
    Vazquez, Rocio
    Patel, Hirai
    Zamanian, Roham T.
    de Jesus Perez, Vinicio A.
    CHEST, 2022, 161 (04) : 1060 - 1072
12345